NIH-funded research NIH-funded research

Developing new vaccines for infectious diseases

Official title: Task V03: Product Development Plans

Funded at International AIDS Vaccine Initiative · NIH-10390262 · Data updated 2026-11-12

This study is all about developing and improving new vaccines to help fight infectious diseases, making sure they meet safety standards so they can be approved for use and ultimately help keep everyone healthier.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionInternational AIDS Vaccine Initiative
NIH-funded
Lab location1 site (New York, United States)
Project startMay 15, 2018
Project endMay 14, 2028
Funding year2021
Award (this year)$666,400
NIH project number272201800010I-P00002-759301900131-1
Project IDNIH-10390262 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of infectious diseases who may benefit from new vaccine options.

Less likely to help

Patients who are not at risk for infectious diseases or those who have already been vaccinated against the targeted pathogens may not receive benefit from this research.

What this research studies

This research focuses on creating and optimizing new vaccines and biologics to combat infectious diseases. It involves planning product development, conducting feasibility assessments, and ensuring compliance with manufacturing standards for clinical studies. The project also includes technical audits and regulatory support to facilitate the submission of new vaccines to the U.S. Food and Drug Administration (FDA). By advancing vaccine technology, this research aims to improve public health outcomes.

Why it matters

Potential benefit: If successful, this research could lead to the development of effective vaccines that protect against various infectious diseases.

How similar studies have gone: Previous research has shown success in developing vaccines using similar methodologies, indicating a promising potential for this approach.

Where this research is happening

  • International AIDS Vaccine Initiative
    New York, United States
    Active

Researchers

  • Principal investigator: Hassell, Thomas — International AIDS Vaccine Initiative
  • Study coordinator: Hassell, Thomas

Related research

Other NIH-funded projects on the same topics.

  • Creating vaccines for influenza and other infectious diseases

    This study is all about creating new vaccines to help protect people from the flu and other infections, so patients can look forward to better options for staying healthy.

    NIH research International AIDS Vaccine Initiative · New York, United States · NIH-9952278

  • Developing vaccines and biologics for infectious diseases

    This study is working on creating and improving vaccines to help protect people from infectious diseases like the flu and Nipah virus, so that patients can have better options for staying healthy.

    NIH research International AIDS Vaccine Initiative · New York, United States · NIH-9916844

  • Creating vaccines for human trials against influenza and other infectious diseases

    This study is working on creating new vaccines to help protect people from flu and other infectious diseases, including those that could be used in harmful situations, so that everyone can have safer and more effective options to stay healthy.

    NIH research International AIDS Vaccine Initiative · New York, United States · NIH-9789450

  • Developing and producing new vaccines for infectious diseases.

    This study is all about creating and testing new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism or drug-resistant germs, so that patients can have better options for staying healthy.

    NIH research International AIDS Vaccine Initiative · New York, United States · NIH-9724120

  • New mRNA vaccines to prevent tuberculosis for adolescents and adults

    A new mRNA vaccine approach aims to prevent TB in teens and adults and reduce transmission, using advanced vaccine technology.

    NIH research International AIDS Vaccine Initiative · New York, United States · NIH-11360153

  • New mRNA Vaccines for Tuberculosis

    This research explores new mRNA vaccine technology to protect adolescents and adults from tuberculosis, a serious lung infection.

    NIH research International AIDS Vaccine Initiative · New York, United States · NIH-11325903

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.